Catalyst Pharmaceuticals Inc 2024 Sustainability Report
Company: Catalyst Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2024
Type: Sustainability Report
Pages: 55
The report describes Catalyst's first public measurement of Scope 1 and 2 emissions in 2024, reporting 3.6 and 51.0 MTCO 2 e, respectively. It reports 491,734,000 Dollars ($) in total revenues and 196 year-end employees. The company also outlines Board-level ESG oversight and a materiality assessment.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.